UPDATED 5:00 PM PT – Friday, February 26, 2021
The U.S. government agreed to buy 100,000 doses of Eli Lilly’s COVID antibody therapy. According to that deal, which was announced Friday, the U.S. will pay $210 million for the doses.
Biden Administration purchases 100,000 treatment courses of Eli Lilly antibody cocktail for #covid19 for $210m, with option to buy 1.2M more through November pic.twitter.com/vTGrsrox0P
— Meg Tirrell (@megtirrell) February 26, 2021
Eli Lilly is expected to ship the doses out by the end of March. The government will also have the option to buy 1.1 million more doses of the treatment through the end of November.
Today, Lilly announced an agreement with the U.S. government to provide doses of our investigational neutralizing antibodies administered together for the treatment of mild to moderate #COVID19 in high-risk patients. Learn more: https://t.co/V1rfceMyLR pic.twitter.com/DQCobQURhY
— Eli Lilly and Company (@LillyPad) February 26, 2021
Eli Lilly’s antibody cocktail received Emergency Use Authorization in November for use in high-risk COVID-19 patients.
While vaccines may prevent #COVID19, monoclonal antibody treatments could improve COVID-19 symptoms in certain people and help them stay out of the hospital. Learn more: https://t.co/Krfz2EYvMU pic.twitter.com/GWf0QQ0X2C
— Eli Lilly and Company (@LillyPad) February 25, 2021
Be the first to comment